XNAS · Healthcare · Medical Devices
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | Q1 2026 | -0.10 | -0.16 | -60.00% | $3.4M | ❌ Miss | -19.77% | -12.17% | — |
| 2026-02-12 | Q4 2025 | -0.07 | -0.19 | -171.43% | $4.9M | ❌ Miss | -18.89% | -15.91% | -16.34% |
| 2025-11-06 |
| Q3 2025 |
| -0.11 |
| -0.06 |
| +45.45% |
| $6.9M |
| ✅ Beat |
| — |
| — |
| — |
| 2024-11-14 | Q3 2024 | -0.01 | 0.07 | +800.00% | $8.8M | ✅ Beat | +4.80% | +22.50% | +9.33% |
| 2024-08-08 | Q2 2024 | 0.02 | 0.10 | +400.00% | $9.2M | ✅ Beat | +1.43% | +1.43% | -7.94% |
| 2024-02-08 | Q4 2023 | 0.12 | 0.26 | +116.67% | $12.6M | ✅ Beat | — | — | — |
| 2023-11-09 | Q3 2023 | -0.02 | -0.09 | -350.00% | $3.9M | ❌ Miss | -14.41% | -5.41% | -4.50% |
| 2023-05-03 | Q1 2023 | 0.13 | -0.12 | -192.31% | $3.4M | ❌ Miss | -44.38% | -39.88% | -44.79% |
Showing last 8 quarters.